RBC Capital analyst Mark Dwelle lowered the firm’s price target on MetLife to $76 from $83 but keeps an Outperform rating on the shares. The analyst is updating the firm’s model to reflect the recently recast financial statements that incorporate new LDTI accounting standards. The firm remains positive on the stock however, noting that MetLife is trading at an attractive valuation and offers relatively lower sensitivity to interest rates and market volatility.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MET: